HIV Vaccines

Currently there is no vaccine available for HIV to prevent or treatment. The long term goal is to develop safe, effective and affordable vaccines for preventing the infection in uninfected people. The difficulties faced by researchers in developing the HIV vaccines are that HIV structure changes frequently and HIV isolates are themselves highly variable.

  • HIV Vaccine Development
  • Therapeutic HIV Vaccine
  • HIV Vaccines Side Effects
  • Clinical Trials
  • Viral Toxin Vaccines
  • Live-Attenuated Vaccines
  • Peptide Vaccines
  • T-Cell Based Vaccines
  • B-Cell Based Vaccines
  • Vaccine Development Challenges
  • Current Scenario and Future Aspects

Related Conference of HIV Vaccines

March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
June 13-14, 2019

2nd International Conference on Vaccine Research

Paris, France
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand
October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia

HIV Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in